149 related articles for article (PubMed ID: 36241061)
21. Quantification of serum free light chain kappa and lambda by the SPAPLUS analyser.
Maisin D; Lepoutre T; Gruson D; Wallemacq P
Clin Biochem; 2013 May; 46(7-8):622-6. PubMed ID: 23291296
[TBL] [Abstract][Full Text] [Related]
22. Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains.
Katzmann JA; Clark RJ; Abraham RS; Bryant S; Lymp JF; Bradwell AR; Kyle RA
Clin Chem; 2002 Sep; 48(9):1437-44. PubMed ID: 12194920
[TBL] [Abstract][Full Text] [Related]
23. Serum Free Light Chain Quantification Testing: Comparison of Two Methods for Disease Monitoring.
Singh G; Whitaker BM; Wu AHB; Xu H; Bollag RJ
J Appl Lab Med; 2022 Oct; 7(6):1290-1301. PubMed ID: 36006797
[TBL] [Abstract][Full Text] [Related]
24. Reference intervals and diagnostic ranges for serum free κ and free λ immunoglobulin light chains vary by instrument platform: Implications for classification of patient results in a multi-center study.
Cotten SW; Shajani-Yi Z; Cervinski MA; Voorhees T; Tuchman SA; Korpi-Steiner N
Clin Biochem; 2018 Aug; 58():100-107. PubMed ID: 29885308
[TBL] [Abstract][Full Text] [Related]
25. FLC polymerization: Another hurdle towards standardization of FLC measurements.
Kaplan B; Jacobs JFM
Clin Chim Acta; 2021 Apr; 515():42-43. PubMed ID: 33388308
[TBL] [Abstract][Full Text] [Related]
26. Comparison of two serum free light chain assays for the diagnosis of primary plasma cell malignant proliferative disease.
Yang Y; Han X; Zheng G; Cai Z
Health Sci Rep; 2019 Apr; 2(4):e113. PubMed ID: 31049418
[TBL] [Abstract][Full Text] [Related]
27. Using Two Detection Methods to Observe the Changes and Significance of Free Light Chain in Serum and Urine in Patients with Renal Insufficiency.
Xu L; Zhao B; Sun Y; Wang S; Chen X; Mao Y
Biomed Res Int; 2022; 2022():5536199. PubMed ID: 35392256
[TBL] [Abstract][Full Text] [Related]
28. Verification of Newly FDA-Approved Kappa and Lambda Free Light Chain Assays on a Previously Untested Platform.
Muluhngwi P; Sharp CN; Pozzi N; Elin RJ; Jortani SA
J Appl Lab Med; 2019 Nov; 4(3):323-330. PubMed ID: 31659070
[TBL] [Abstract][Full Text] [Related]
29. A multicentre study comparing two methods for serum free light chain analysis.
Lock RJ; Saleem R; Roberts EG; Wallage MJ; Pesce TJ; Rowbottom A; Cooper SJ; McEvoy ED; Taylor JL; Basu S
Ann Clin Biochem; 2013 May; 50(Pt 3):255-61. PubMed ID: 23605135
[TBL] [Abstract][Full Text] [Related]
30. Serum free light chain analysis: persisting limitations with new kids on the block.
Van Hoovels L; Vercammen M; Nevejan L; Cornette M; Briers PJ; Deeren D; Van Droogenbroeck J; Fostier K; De Smet D
Clin Chem Lab Med; 2022 Aug; 60(9):1440-1448. PubMed ID: 35781357
[TBL] [Abstract][Full Text] [Related]
31. Method comparison of four clinically available assays for serum free light chain analysis.
Fleming CKA; Swarttouw T; de Kat Angelino CM; Jacobs JFM; Russcher H
Clin Chem Lab Med; 2019 Dec; 58(1):85-94. PubMed ID: 31730518
[TBL] [Abstract][Full Text] [Related]
32. Rapid detection of serum free light chains by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
Kaya ZZ; Serdar M; Aksungar F; Kilercik M; Serteser M; Baykal AT
Eur J Mass Spectrom (Chichester); 2023 Apr; 29(2):132-140. PubMed ID: 36734073
[No Abstract] [Full Text] [Related]
33. Diagnostic performance of quantitative kappa and lambda free light chain assays in clinical practice.
Katzmann JA; Abraham RS; Dispenzieri A; Lust JA; Kyle RA
Clin Chem; 2005 May; 51(5):878-81. PubMed ID: 15774572
[TBL] [Abstract][Full Text] [Related]
34. Different immunoreactivity of monomers and dimers makes automated free light chains assays not equivalent.
Caponi L; Koni E; Romiti N; Paolicchi A; Franzini M
Clin Chem Lab Med; 2018 Dec; 57(2):221-229. PubMed ID: 30032127
[TBL] [Abstract][Full Text] [Related]
35. Development of a highly-sensitive multi-plex assay using monoclonal antibodies for the simultaneous measurement of kappa and lambda immunoglobulin free light chains in serum and urine.
Campbell JP; Cobbold M; Wang Y; Goodall M; Bonney SL; Chamba A; Birtwistle J; Plant T; Afzal Z; Jefferis R; Drayson MT
J Immunol Methods; 2013 May; 391(1-2):1-13. PubMed ID: 23388695
[TBL] [Abstract][Full Text] [Related]
36. Serum free light chain reference intervals in an Optilite and their influence on clinical guidelines.
Morales-García LJ; Pacheco-Delgado MS
Clin Biochem; 2021 Jun; 92():54-60. PubMed ID: 33662349
[TBL] [Abstract][Full Text] [Related]
37. Freelite and Kloneus assays in free light chain measurements in patients with renal impairment.
Morales-García LJ; Lillo Rodríguez RM; Pacheco-Delgado MS
Clin Biochem; 2023 Aug; 118():110610. PubMed ID: 37429509
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of the N Latex FLC free light chain assay on the Siemens BN analyser: precision, agreement, linearity and variation between reagent lots.
Pretorius CJ; Klingberg S; Tate J; Wilgen U; Ungerer JP
Ann Clin Biochem; 2012 Sep; 49(Pt 5):450-5. PubMed ID: 22764186
[TBL] [Abstract][Full Text] [Related]
39. Development of a rapid and quantitative lateral flow assay for the simultaneous measurement of serum κ and λ immunoglobulin free light chains (FLC): inception of a new near-patient FLC screening tool.
Campbell JP; Heaney JL; Shemar M; Baldwin D; Griffin AE; Oldridge E; Goodall M; Afzal Z; Plant T; Cobbold M; Jefferis R; Jacobs JF; Hand C; Drayson MT
Clin Chem Lab Med; 2017 Mar; 55(3):424-434. PubMed ID: 27505089
[TBL] [Abstract][Full Text] [Related]
40. Free light chain UV quantification compared with immunochemical measurement: How dimers and monomers may influence the results.
Caponi L; Koni E; Romiti N; Paolicchi A; Franzini M
Clin Chim Acta; 2020 Nov; 510():278-284. PubMed ID: 32702433
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
